|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019704,
umls-concept:C0024432,
umls-concept:C0086418,
umls-concept:C0205225,
umls-concept:C0209738,
umls-concept:C0282519,
umls-concept:C0439801,
umls-concept:C0449258,
umls-concept:C0683598,
umls-concept:C1527148,
umls-concept:C1579410
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2005-6-10
|
|
pubmed:abstractText |
The aim of this study was to investigate the development and progression of phenotypic resistance to the HIV-1-reverse transcriptase (RT) inhibitor lamivudine, and genotypic variations of HIV-1-RT occurring under lamivudine treatment in HIV-1-infected human primary monocytes-macrophages (M/M).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0305-7453
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
872-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15845785-Anti-HIV Agents,
pubmed-meshheading:15845785-Cells, Cultured,
pubmed-meshheading:15845785-Drug Resistance, Viral,
pubmed-meshheading:15845785-HIV Reverse Transcriptase,
pubmed-meshheading:15845785-HIV-1,
pubmed-meshheading:15845785-Humans,
pubmed-meshheading:15845785-Lamivudine,
pubmed-meshheading:15845785-Macrophages,
pubmed-meshheading:15845785-Mutation,
pubmed-meshheading:15845785-Reverse Transcriptase Inhibitors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages.
|
|
pubmed:affiliation |
Department of Experimental Medicine and Biochemical Sciences, University of Rome 'Tor Vergata', Via Montpellier 1, 00133 Rome. aquaro@uniroma2.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
